Literature DB >> 26181819

Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women.

Cecile D Lahiri1, Katherine B Dugan, Xianhong Xie, Laura Reimers, Robert D Burk, Kathryn Anastos, Leslie Stewart Massad, Isam-Eldin Eltoum, Xiaonan Xue, Gypsyamber DʼSouza, Lisa Flowers, Joel M Palefsky, Lisa Rahangdale, Howard D Strickler, Ighovwerha Ofotokun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26181819      PMCID： PMC4573346          DOI： 10.1097/QAI.0000000000000752

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  27 in total

1.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

2.  The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.

Authors:  H Minkoff; L Ahdieh; L S Massad; K Anastos; D H Watts; S Melnick; L Muderspach; R Burk; J Palefsky
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

3.  Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions.

Authors:  Ingeborg Zehbe; Christina Richard; Kyle F Lee; Michael Campbell; Lynne Hampson; Ian N Hampson
Journal:  Antiviral Res       Date:  2011-06-02       Impact factor: 5.970

4.  Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells.

Authors:  Gavin Batman; Anthony W Oliver; Ingeborg Zehbe; Christina Richard; Lynne Hampson; Ian N Hampson
Journal:  Antivir Ther       Date:  2011

5.  Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.

Authors:  David H Adler; Lisa Kakinami; Tebogo Modisenyane; Nkeko Tshabangu; Lerato Mohapi; Guy De Bruyn; Neil A Martinson; Tanvier Omar
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

6.  Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.

Authors:  M Temmerman; M W Tyndall; N Kidula; P Claeys; L Muchiri; W Quint
Journal:  Int J Gynaecol Obstet       Date:  1999-05       Impact factor: 3.561

7.  Human papillomavirus infection in women infected with the human immunodeficiency virus.

Authors:  X W Sun; L Kuhn; T V Ellerbrock; M A Chiasson; T J Bush; T C Wright
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

Review 8.  Cervical and anal HPV infections in HIV positive women and men.

Authors:  Silvia de Sanjosé; Joel Palefsky
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

9.  Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women.

Authors:  Isabelle Heard; Jean-Michel Tassie; Michel D Kazatchkine; Gérard Orth
Journal:  AIDS       Date:  2002-09-06       Impact factor: 4.177

10.  Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.

Authors:  Howard Minkoff; Ye Zhong; Robert D Burk; Joel M Palefsky; Xiaonan Xue; D Heather Watts; Alexandra M Levine; Rodney L Wright; Christine Colie; Gypsyamber D'Souza; L Stewart Massad; Howard D Strickler
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226
View more
  2 in total

1.  Increased CD4+ T cell count is associated with lower anal human papillomavirus prevalence among HIV-positive male cohort in Taizhou, China: a cross-sectional study.

Authors:  Jing Zhang; Xiaoxiao Chen; Yiwen Ye; Weiwei Shen; Xiaohong Ye; Yajun Lin; Zhebin Lin; Shigang Tan; Meiyang Gao; Yingying Ding; Haijiang Lin; Youyi Wang; Na He; Xing Liu
Journal:  BMC Infect Dis       Date:  2022-03-14       Impact factor: 3.090

2.  A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease.

Authors:  Lynne Hampson; Innocent O Maranga; Millicent S Masinde; Anthony W Oliver; Gavin Batman; Xiaotong He; Minaxi Desai; Parmenas M Okemwa; Helen Stringfellow; Pierre Martin-Hirsch; Alex M Mwaniki; Peter Gichangi; Ian N Hampson
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.